| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 650365 | Null | 0.0260391472224207 | 0.052994798 |
| NSC 668483 | Null | 0.0260391472224207 | 0.19712824 |
| NSC 676555 | Null | 0.0260391472224207 | -0.14748628 |
| NSC 736553 | Ethyl 3-[4'-(thien-3''-yl)-1',2'-dihydronaphthalen-3'-yl]acrylate | 0.0260391472224207 | 0.46944271 |
| NSC 107043 | Null | 0.0267520285931239 | 0.32466664 |
| NSC 114340 | Ophiobolin A | 0.0267520285931239 | 0.44512263 |
| NSC 128635 | Null | 0.0267520285931239 | 0.13879556 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0267520285931239 | 0.33034865 |
| NSC 292816 | 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) | 0.0267520285931239 | 0.028936243 |
| NSC 375162 | Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide | 0.0267520285931239 | 0.27346819 |